Genetic association between endothelial nitric oxide synthase and Alzheimer disease

A. Akomolafe, K. L. Lunetta, P. M. Erlich, L. A. Cupples, C. T. Baldwin, M. Huyck, R. C. Green, Lindsay A. Farrer, S. Auerbach, P. Griffith, E. Ofili, J. Browndyke, D. Schmechel, K. Welsh-Bohmer, H. Chui, C. DeCarli, R. Duara, Tatiana Foroud, Martin Farlow, R. FriedlandR. Go, A. Kurz, T. Obisesan, H. Petrovitch, L. White, N. Relkin, M. Sabbagh, D. Sadovnick, M. Tsolaki

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Evidence suggests that vascular and inflammatory factors may be important in the etiology of Alzheimer disease (AD). The Glu/Glu genotype at the Glu298Asp variant of the endothelial nitric oxide synthase (NOS3) gene has been tested for association with AD in several Caucasian and Asian populations, with conflicting results. We tested the Glu298Asp variant for association in African American and Caucasian AD patients, unaffected siblings, and unrelated controls from the MIRAGE Study. To explore whether the inconsistent results in previous studies might be due to linkage disequilibrium with a polymorphism or haplotype not previously tested, we genotyped 10 additional NOS3 single nucleotide polymorphisms (SNPs) spanning 25.3 kb. Finally, we compiled results of previous studies of Glu298Asp using meta-analysis, to determine whether the aggregate studies support an association between Glu298Asp and AD. We found that the Glu298 allele was associated with higher risk of AD in the MIRAGE African American (p = 0.002) but not Caucasian (p = 0.9) groups. None of the additional SNPs were associated with AD in the Caucasians, whereas two showed evidence for association in the African Americans. The meta-analysis showed a small effect of the Glu298Asp GG genotype on AD risk across all studies (summary odds ratio = 1.15, 95% confidence interval: 0.97-1.35) and significant heterogeneity of this association among studies (p = 0.02).

Original languageEnglish
Pages (from-to)49-56
Number of pages8
JournalClinical Genetics
Volume70
Issue number1
DOIs
StatePublished - Jul 2006

Fingerprint

Nitric Oxide Synthase Type III
Alzheimer Disease
African Americans
Single Nucleotide Polymorphism
Meta-Analysis
Genotype
Linkage Disequilibrium
Haplotypes
Siblings
Alleles
Odds Ratio
Confidence Intervals
Population
Genes

Keywords

  • Alzheimer disease
  • Endothelial nitric oxide synthase
  • Genetic association
  • Glu298Asp
  • Haplotype analysis
  • Single nucleotide polymorphism

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Akomolafe, A., Lunetta, K. L., Erlich, P. M., Cupples, L. A., Baldwin, C. T., Huyck, M., ... Tsolaki, M. (2006). Genetic association between endothelial nitric oxide synthase and Alzheimer disease. Clinical Genetics, 70(1), 49-56. https://doi.org/10.1111/j.1399-0004.2006.00638.x

Genetic association between endothelial nitric oxide synthase and Alzheimer disease. / Akomolafe, A.; Lunetta, K. L.; Erlich, P. M.; Cupples, L. A.; Baldwin, C. T.; Huyck, M.; Green, R. C.; Farrer, Lindsay A.; Auerbach, S.; Griffith, P.; Ofili, E.; Browndyke, J.; Schmechel, D.; Welsh-Bohmer, K.; Chui, H.; DeCarli, C.; Duara, R.; Foroud, Tatiana; Farlow, Martin; Friedland, R.; Go, R.; Kurz, A.; Obisesan, T.; Petrovitch, H.; White, L.; Relkin, N.; Sabbagh, M.; Sadovnick, D.; Tsolaki, M.

In: Clinical Genetics, Vol. 70, No. 1, 07.2006, p. 49-56.

Research output: Contribution to journalArticle

Akomolafe, A, Lunetta, KL, Erlich, PM, Cupples, LA, Baldwin, CT, Huyck, M, Green, RC, Farrer, LA, Auerbach, S, Griffith, P, Ofili, E, Browndyke, J, Schmechel, D, Welsh-Bohmer, K, Chui, H, DeCarli, C, Duara, R, Foroud, T, Farlow, M, Friedland, R, Go, R, Kurz, A, Obisesan, T, Petrovitch, H, White, L, Relkin, N, Sabbagh, M, Sadovnick, D & Tsolaki, M 2006, 'Genetic association between endothelial nitric oxide synthase and Alzheimer disease', Clinical Genetics, vol. 70, no. 1, pp. 49-56. https://doi.org/10.1111/j.1399-0004.2006.00638.x
Akomolafe A, Lunetta KL, Erlich PM, Cupples LA, Baldwin CT, Huyck M et al. Genetic association between endothelial nitric oxide synthase and Alzheimer disease. Clinical Genetics. 2006 Jul;70(1):49-56. https://doi.org/10.1111/j.1399-0004.2006.00638.x
Akomolafe, A. ; Lunetta, K. L. ; Erlich, P. M. ; Cupples, L. A. ; Baldwin, C. T. ; Huyck, M. ; Green, R. C. ; Farrer, Lindsay A. ; Auerbach, S. ; Griffith, P. ; Ofili, E. ; Browndyke, J. ; Schmechel, D. ; Welsh-Bohmer, K. ; Chui, H. ; DeCarli, C. ; Duara, R. ; Foroud, Tatiana ; Farlow, Martin ; Friedland, R. ; Go, R. ; Kurz, A. ; Obisesan, T. ; Petrovitch, H. ; White, L. ; Relkin, N. ; Sabbagh, M. ; Sadovnick, D. ; Tsolaki, M. / Genetic association between endothelial nitric oxide synthase and Alzheimer disease. In: Clinical Genetics. 2006 ; Vol. 70, No. 1. pp. 49-56.
@article{3f14a4456ff74c57842835fc904c9ced,
title = "Genetic association between endothelial nitric oxide synthase and Alzheimer disease",
abstract = "Evidence suggests that vascular and inflammatory factors may be important in the etiology of Alzheimer disease (AD). The Glu/Glu genotype at the Glu298Asp variant of the endothelial nitric oxide synthase (NOS3) gene has been tested for association with AD in several Caucasian and Asian populations, with conflicting results. We tested the Glu298Asp variant for association in African American and Caucasian AD patients, unaffected siblings, and unrelated controls from the MIRAGE Study. To explore whether the inconsistent results in previous studies might be due to linkage disequilibrium with a polymorphism or haplotype not previously tested, we genotyped 10 additional NOS3 single nucleotide polymorphisms (SNPs) spanning 25.3 kb. Finally, we compiled results of previous studies of Glu298Asp using meta-analysis, to determine whether the aggregate studies support an association between Glu298Asp and AD. We found that the Glu298 allele was associated with higher risk of AD in the MIRAGE African American (p = 0.002) but not Caucasian (p = 0.9) groups. None of the additional SNPs were associated with AD in the Caucasians, whereas two showed evidence for association in the African Americans. The meta-analysis showed a small effect of the Glu298Asp GG genotype on AD risk across all studies (summary odds ratio = 1.15, 95{\%} confidence interval: 0.97-1.35) and significant heterogeneity of this association among studies (p = 0.02).",
keywords = "Alzheimer disease, Endothelial nitric oxide synthase, Genetic association, Glu298Asp, Haplotype analysis, Single nucleotide polymorphism",
author = "A. Akomolafe and Lunetta, {K. L.} and Erlich, {P. M.} and Cupples, {L. A.} and Baldwin, {C. T.} and M. Huyck and Green, {R. C.} and Farrer, {Lindsay A.} and S. Auerbach and P. Griffith and E. Ofili and J. Browndyke and D. Schmechel and K. Welsh-Bohmer and H. Chui and C. DeCarli and R. Duara and Tatiana Foroud and Martin Farlow and R. Friedland and R. Go and A. Kurz and T. Obisesan and H. Petrovitch and L. White and N. Relkin and M. Sabbagh and D. Sadovnick and M. Tsolaki",
year = "2006",
month = "7",
doi = "10.1111/j.1399-0004.2006.00638.x",
language = "English",
volume = "70",
pages = "49--56",
journal = "Clinical Genetics",
issn = "0009-9163",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Genetic association between endothelial nitric oxide synthase and Alzheimer disease

AU - Akomolafe, A.

AU - Lunetta, K. L.

AU - Erlich, P. M.

AU - Cupples, L. A.

AU - Baldwin, C. T.

AU - Huyck, M.

AU - Green, R. C.

AU - Farrer, Lindsay A.

AU - Auerbach, S.

AU - Griffith, P.

AU - Ofili, E.

AU - Browndyke, J.

AU - Schmechel, D.

AU - Welsh-Bohmer, K.

AU - Chui, H.

AU - DeCarli, C.

AU - Duara, R.

AU - Foroud, Tatiana

AU - Farlow, Martin

AU - Friedland, R.

AU - Go, R.

AU - Kurz, A.

AU - Obisesan, T.

AU - Petrovitch, H.

AU - White, L.

AU - Relkin, N.

AU - Sabbagh, M.

AU - Sadovnick, D.

AU - Tsolaki, M.

PY - 2006/7

Y1 - 2006/7

N2 - Evidence suggests that vascular and inflammatory factors may be important in the etiology of Alzheimer disease (AD). The Glu/Glu genotype at the Glu298Asp variant of the endothelial nitric oxide synthase (NOS3) gene has been tested for association with AD in several Caucasian and Asian populations, with conflicting results. We tested the Glu298Asp variant for association in African American and Caucasian AD patients, unaffected siblings, and unrelated controls from the MIRAGE Study. To explore whether the inconsistent results in previous studies might be due to linkage disequilibrium with a polymorphism or haplotype not previously tested, we genotyped 10 additional NOS3 single nucleotide polymorphisms (SNPs) spanning 25.3 kb. Finally, we compiled results of previous studies of Glu298Asp using meta-analysis, to determine whether the aggregate studies support an association between Glu298Asp and AD. We found that the Glu298 allele was associated with higher risk of AD in the MIRAGE African American (p = 0.002) but not Caucasian (p = 0.9) groups. None of the additional SNPs were associated with AD in the Caucasians, whereas two showed evidence for association in the African Americans. The meta-analysis showed a small effect of the Glu298Asp GG genotype on AD risk across all studies (summary odds ratio = 1.15, 95% confidence interval: 0.97-1.35) and significant heterogeneity of this association among studies (p = 0.02).

AB - Evidence suggests that vascular and inflammatory factors may be important in the etiology of Alzheimer disease (AD). The Glu/Glu genotype at the Glu298Asp variant of the endothelial nitric oxide synthase (NOS3) gene has been tested for association with AD in several Caucasian and Asian populations, with conflicting results. We tested the Glu298Asp variant for association in African American and Caucasian AD patients, unaffected siblings, and unrelated controls from the MIRAGE Study. To explore whether the inconsistent results in previous studies might be due to linkage disequilibrium with a polymorphism or haplotype not previously tested, we genotyped 10 additional NOS3 single nucleotide polymorphisms (SNPs) spanning 25.3 kb. Finally, we compiled results of previous studies of Glu298Asp using meta-analysis, to determine whether the aggregate studies support an association between Glu298Asp and AD. We found that the Glu298 allele was associated with higher risk of AD in the MIRAGE African American (p = 0.002) but not Caucasian (p = 0.9) groups. None of the additional SNPs were associated with AD in the Caucasians, whereas two showed evidence for association in the African Americans. The meta-analysis showed a small effect of the Glu298Asp GG genotype on AD risk across all studies (summary odds ratio = 1.15, 95% confidence interval: 0.97-1.35) and significant heterogeneity of this association among studies (p = 0.02).

KW - Alzheimer disease

KW - Endothelial nitric oxide synthase

KW - Genetic association

KW - Glu298Asp

KW - Haplotype analysis

KW - Single nucleotide polymorphism

UR - http://www.scopus.com/inward/record.url?scp=33746863741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746863741&partnerID=8YFLogxK

U2 - 10.1111/j.1399-0004.2006.00638.x

DO - 10.1111/j.1399-0004.2006.00638.x

M3 - Article

C2 - 16813604

AN - SCOPUS:33746863741

VL - 70

SP - 49

EP - 56

JO - Clinical Genetics

JF - Clinical Genetics

SN - 0009-9163

IS - 1

ER -